Chris E Holmes MD PhD
Clotting Disorder, Hematologic Oncology, Hemophilia & Bleeding Disorder
Professor, Department of Medicine, University of Vermont College of Medicine
Join to View Full Profile
111 Colchester AveSecond floor ACCBurlington, VT 05401
Phone+1 802-847-8400
Dr. Holmes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004- University of Vermont Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Virginia School of MedicineClass of 1997
Certifications & Licensure
VT State Medical License 2001 - 2026
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Treatment Trial for Post-Thrombotic Syndrome Start of enrollment: 2008 Mar 01
- The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy Start of enrollment: 2008 Jul 01
- Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Acute myocardial infarction in patients with cancer: outcomes and P2Y12 inhibition.Andres Cordova Sanchez, Chris E Holmes, Harold L Dauerman, Tanush Gupta
Journal of Thrombosis and Thrombolysis. 2025-04-01 - Anticoagulation and Other Risk Factors for Clinically Relevant Bleeding after Medical Hospitalization: The Medical Inpatient Thrombosis and Hemostasis Study.Mansour Gergi, Katherine Wilkinson, Andrew Sparks, Nicholas S Roetker, Hanny Al-Samkari
Journal of Thrombosis and Haemostasis. 2025-03-21 - Venous thromboembolism (VTE) prevention program implementation in a community oncology practice: author response to Yang et al.Steven Ades, Chris Holmes
Lancet Regional Health. Americas. 2025-02-01
Abstracts/Posters
- Post Discharge Risk of Venous Thromboembolism in a Primary Care PopulationChris E. Holmes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Bleeding Risk in a Cohort of Ambulatory Cancer Patients Receiving Outpatient Prophylactic Anticoagulation for Venous Thrombosis PreventionChris E. Holmes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
UVM Cancer Center Rolls Out Custom-Made ImmunotherapyFebruary 22nd, 2023- Holcombe Named Director of UVM Cancer Center and Chief of Hematology/OncologyApril 13th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
